HQH Logo

Tekla Healthcare Investors (HQH) 

NYSE
Market Cap
$787.64M
Sector
Financial Services
Industry
Asset Management
Rank in Sector
237 of 647
Rank in Industry
47 of 103

Largest Insider Buys in Sector

HQH Stock Price History Chart

HQH Stock Performance

About Tekla Healthcare Investors

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced …

Insider Activity of Tekla Healthcare Investors

Over the last 12 months, insiders at Tekla Healthcare Investors have bought $61,011 and sold $0 worth of Tekla Healthcare Investors stock.

On average, over the past 5 years, insiders at Tekla Healthcare Investors have bought $202,894 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: DiMartino Rose (director) — $37,760. Reit Todd (director) — $33,858. Maher Bill (director) — $33,160.

The last purchase of 1,000 shares for transaction amount of $18,880 was made by DiMartino Rose (director) on 2024‑07‑16.

List of Insider Buy and Sell Transactions, Tekla Healthcare Investors

2024-07-16Purchasedirector
1,000
0.0022%
$18.88$18,880+0.28%
2024-04-09Purchasedirector
525
0.001%
$16.42$8,622+17.01%
2024-01-02Purchasedirector
1,000
0.002%
$16.93$16,929+9.85%
2023-12-28Purchasedirector
1,000
0.002%
$16.58$16,580+12.04%
2023-12-21PurchaseVice President
170
0.0003%
$16.13$2,742+13.77%
2023-09-25PurchasePresident
9,500
0.0176%
$15.63$148,515+13.65%
2023-09-20PurchasePresident
9,500
0.0179%
$15.88$150,829+12.56%
2022-03-23Purchase
73.53
0.0002%
$20.42$1,501-2.44%
2022-01-26Purchasedirector
481
0.0012%
$21.52$10,349-4.38%
2020-10-26PurchasePresident
5,200
0.0127%
$20.53$106,744+25.96%
2020-10-21PurchasePresident
5,050
0.0124%
$20.68$104,427+26.31%
2020-09-23Purchasedirector
490
0.0012%
$20.39$9,991+26.68%
2020-05-21PurchasePresident
5,000
0.0125%
$21.01$105,054+8.26%
2020-03-17PurchasePresident
6,800
0.0131%
$16.24$110,412+35.42%
2018-12-26PurchasePresident
6,300
0.0128%
$17.14$107,971+16.80%
2018-10-25PurchasePresident
5,500
0.0133%
$20.43$112,344+2.40%
2018-10-17PurchasePresident
3,882
0.01%
$21.78$84,534-4.72%
2018-01-25Purchasedirector
1,100
0.0032%
$24.19$26,605-7.29%
2016-01-06Purchase
862
0.003%
$28.98$24,978-12.40%
2015-06-29Purchasedirector
2,000
0.0085%
$35.74$71,480-14.20%

Insider Historical Profitability

9.88%
Goetz Kathleendirector
1080
0.0022%
$16.2930<0.0001%
Maher Billdirector
1000
0.0021%
$16.2910
Reit Todddirector
1000
0.0021%
$16.2910
DiMartino Rosedirector
1000
0.0021%
$16.2910
OMSTEAD DANIEL RPresident
178269
0.3687%
$16.29190+13.57%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.